logo
Conservative group files federal complaint against UConn over DEI scholarships

Conservative group files federal complaint against UConn over DEI scholarships

Yahoo29-05-2025
A conservative group that's pursuing anti-DEI complaints against more than a dozen state universities on Wednesday targeted the University of Connecticut, accusing the school of violating civil rights law by setting aside numerous scholarships exclusively or chiefly for minority students.
The Rhode Island-based Equal Protection Project complained to the federal education department's Office of Civil Rights that UConn illegally invoked race, ethnicity or gender in awarding several scholarships.
'That racially discriminatory scholarships exist at a major public university is disheartening. It is time for higher education everywhere to focus on the inherent worth and dignity of every student rather than categorizing students based on identity groups,' according to William A. Jacobson, founder of the campaign.
Numerous universities and colleges maintain 'minority-focused' scholarships, internship programs, summer residencies or other financial aid tools aimed at increasing enrollment by Black, Hispanic or other student groups.
Educators contend that affirmative action programs are important to overcoming a historical pattern in which minorities have been under-represented in higher education.
But the Equal Protection Project insists that race- or nationality-based financial awards are unconstitutional.
The U.S. Supreme Court in 2023 ruled that two 'race conscious' admissions programs in higher education violated the Constitution's guarantee of equal protection under the law.
This year, the nonprofit Equal Protection Project has sharply stepped up its campaign of anti-discrimination complaints. Since January it has gone to the Office of Civil Rights to contest scholarships at the University of Oregon, the University of Alabama, the University of Nebraska, Drake University, Bowdoin College, the University of South Carolina and about 15 others.
On Wednesday, the organization announced that it's challenging the legality of four UConn scholarship programs. UConn said late Wednesday that it had not yet gotten a copy of the complaint or been told which funds it involves.
'Generally speaking, UConn continually reviews its scholarship and financial aid criteria against current legal requirements and adjusts as needed to ensure compliance,' UConn spokeswoman Stephanie Reitz said. 'Some such scholarship funds are currently paused following the recent Dear Colleague letter and other related federal guidance, and UConn is working with donors and departments to make any necessary revisions.'
In mid-February, the U.S. Department of Education issued a 'Dear Colleague' letter ordering educational institutions that get federal funding to stop using race preferences as a factor in deciding admissions, discipline, hiring, scholarships and more.
The Equal Protection complaint quotes UConn's mission statement: 'UConn has a strong commitment to Diversity, Equity, Inclusion, and Justice (DEIJ). We aim to support diversity, equity, and inclusion through offering support for success for people of all backgrounds.'
Jacobson's group argues that that's illegal when it blocks non-minority students from being eligible for aid or awards.
'We are asking UConn to live up to the law and its own rules, and remove the discriminatory eligibility barriers it has erected,' the organization said in a statement. 'Racial and ethnic discrimination are wrong and unlawful no matter which race or ethnicity is targeted or benefits. All applicants are entitled to equal treatment without regard to race, color, or national origin.'
In February, Jacobson told ProPublica that his organization opposes any discrimination, saying 'If there are programs that exclude Black students, we want the department to go after that, but I am not aware of such programs.'
At UConn, he contends that Bryan K. and Alice M. Pollard Scholarship rules are discriminatory. They say 'Applicants must have overcome obstacles such as socioeconomic or educational disadvantage, be members of underrepresented groups at the university, including students of color, or have experience living or working in diverse environments.'
The complaint alleges that the Sidney P. Marland Jr. Fund for Educational Leadership is also being run illegally because the criteria say 'The award provides scholarships for minority undergraduate and graduate students in educational leadership.'
He also is challenging a dietetics program diversity scholarship that states 'priority given to candidates of an ethnic or racial background which is underrepresented at UConn,' as well as the Philo T. Pritzkau Fund for graduate students in the Neag School of Education, where the rules say 'priority consideration will be given to African American, Hispanic American and Native American students.'
Long-time civil rights organizations such as the NAACP and the Southern Poverty Law Center condemned the Supreme Court's decision when it came out in 2023.
Voters the next year elected President Trump, who is working to dismantle DEI initiatives across the country. Soon afterward, the federal education department's civil rights office stopped or slowed its review of thousands of civil rights complaints, according to ProPublica. At the same time, it began an investigation into whether universities show bias against white students.
'Let me be clear: it is a new day in America, and under President Trump, OCR will not tolerate discrimination of any kind,' Craig Trainor, acting director of the office, told ProPublica.
The Leadership Conference on Civil and Human Rights takes a different view.
'The American Dream is not equally available to all. In 2023, the Department of Education reported that it received the most civil rights complaints in its history, most of which allege race, sex, or disability discrimination,' according to the group.
'While the number of Black people with college degrees has increased over the last two decades, Black people remain relegated to lower wage jobs and less lucrative industries compared to white people with similar levels of education, and Black women experience some of the largest pay gaps,' it said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, Reckitt, and Tempus and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, Reckitt, and Tempus and Encourages Investors to Contact the Firm

Business Upturn

time2 hours ago

  • Business Upturn

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Vestis, Reckitt, and Tempus and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Vestis (VSTS), Reckitt (RBGLY), or Tempus (TEM) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648 NEW YORK, July 20, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Vestis Corporation (NYSE:VSTS), Reckitt Benckiser Group plc (OTC:RBGLY), and Tempus AI, Inc. (NASDAQ: TEM). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Vestis Corporation (NYSE:VSTS) Class Period: May 2, 2024 – May 6, 2025 Lead Plaintiff Deadline: August 8, 2025 According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of Vestis' ability to grow its business; notably that Vestis would be unable to execute on planned strategic initiatives to drive purported improvements to the customer experience and its onboarding efforts in order to drive new customer growth, increased customer retention, and increased revenue from existing customers. On May 7, 2025, Vestis announced its financial results for the second quarter of fiscal 2025, withdrew its revenue and growth guidance for the full fiscal year 2025, and provided guidance for the third quarter of fiscal 2025 that fell significantly below market expectations. The Company attributed its poor results partially to 'lost business in excess of new business,' but primarily on 'lower adds over stops, which is how we describe volume changes with our existing customers.' The Company attributed its decision to pull full-year guidance and provide disappointing third quarter targets to the 'increasingly uncertain macro environment.' Following this news, the price of Vestis' common stock declined dramatically. From a closing market price of $8.71 per share on May 6, 2025, Vestis' stock price fell to $5.44 per share on May 7, 2025, a decline of about 37.54% in the span of just a single day For more information on the Vestis class action go to: Reckitt Benckiser Group plc (OTC:RBGLY) Class Period: January 13, 2021 – July 28, 2024 Lead Plaintiff Deadline: August 4, 2025 Reckitt is a United Kingdom-based, global consumer goods company. To date, over 500 state and federal products liability lawsuits have been filed against Reckitt and its competitor, Abbott Laboratories ('Abbott'), claiming that they failed to adequately warn that premature infants consuming cow milk-based formulas, such as Reckitt's Enfamil and Abbott's Similac, have an increased risk of developing necrotizing enterocolitis ('NEC'), a life-threatening intestinal disease that affects premature or low birth weight infants. The Class Action alleges that, during the Class Period, Defendants made misleading statements and omissions regarding the Company's business, financial condition, and prospects. Specifically, Defendants failed to warn investors and consumers: (1) that preterm infants were at an increased risk of developing NEC by consuming Reckitt's cow's milk-based formula, Enfamil; (2) of the attendant impact on Reckitt's sales of Enfamil and Reckitt's exposure to legal claims; and (3) as a result of the above, Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. For more information on the Reckitt Bensicker class action go to: Tempus AI, Inc. (NASDAQ: TEM) Class Period: August 6, 2024, and May 27, 2025 Lead Plaintiff Deadline: August 11, 2025 According to the complaint, defendants failed to disclose: (1) Tempus inflated the value of contract agreements, many of which were with related parties, included non-binding opt-ins and/or were self-funded; (2) the credibility and substance of the joint venture with SoftBank was at risk because it gave the appearance of 'round-tripping' capital to create revenue for Tempus; (3) Tempus-acquired Ambry had a business model based on aggressive and potentially unethical billing practices that risked scrutiny and unsustainability; (4) AstraZeneca had reduced its financial commitments to Tempus through a questionable 'pass-through payment' via a joint agreement between it, the Company and Pathos AI; and (5) the foregoing issues revealed weakness in core operations and revenue prospects. The complaint alleges that on May 28, 2025, Spruce Point Capital Management, LLC issued a report on Tempus that raised numerous red flags over Tempus' management, operations and financial reporting. The Spruce Point Report scrutinized Tempus on an array of issues, including: (1) defendant Eric Lefkofsky and his associates have a history cashing out of companies before public shareholders incur losses or lackluster returns; (2) Tempus' actual AI capabilities are overstated; (3) board members and other executives have been associated with troubled companies that restated financial results; (4) signs of aggressive accounting and financial reporting; (4) issues with the AstraZeneca and Pathos AI deal that merit scrutiny; and (5) the Company's recent financial guidance reveals weakness in core operations. On this news, the price of Tempus common stock fell $12.67 per share, or 19.23%, from a closing price of $65.87 per share on May 27, 2025, to a closing price of $53.20 per share on May 28, 2025. For more information on the Elevance class action go to: About Bragar Eagel & Squire, P.C.: Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit . Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information: Bragar Eagel & Squire, Walker, Esq. Marion Passmore, Esq.(212) 355-4648 [email protected]

Upcoming Stock Splits This Week (July 21 to July 25)
Upcoming Stock Splits This Week (July 21 to July 25)

Business Insider

time3 hours ago

  • Business Insider

Upcoming Stock Splits This Week (July 21 to July 25)

These are the upcoming stock splits for the week of July 21 to July 25 on TipRanks' Stock Splits Calendar. A stock split is a corporate move that increases the number of outstanding shares by issuing more to existing shareholders, all while keeping the company's total market value unchanged. This leads to a lower share price, making the stock more accessible and often more appealing to retail investors. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. On the flip side, some companies opt for a reverse stock split. Instead of dividing shares, they consolidate them, reducing the share count and boosting the price per share. While the market cap stays the same, this move is typically aimed at meeting minimum price requirements to maintain exchange listings, like Nasdaq's threshold, and avoid delisting. Whether the goal is to attract retail interest or preserve listing status, these corporate maneuvers can send important signals – and smart traders are always watching. Let's take a look at the upcoming stock splits for the week. Invo Fertility (IVF) – Invo Fertility, known for its innovative fertility treatments and its unique INVOcell device, is taking steps to stay in line with Nasdaq's listing requirements. On July 17, the company announced a 1-for-3 reverse stock split to help boost its share price and maintain compliance with the exchange's minimum bid rule. The split will take effect on July 21. Globavend Holdings (GVH) – Australia-based Globavend Holdings offers cross-border logistics services to e-commerce retailers, focusing on last-mile delivery and freight forwarding. On July 17, the company announced a 1-for-200 reverse stock split of its ordinary shares to increase its share price and meet Nasdaq's continued listing standards. GVH stock is expected to begin trading on a split-adjusted basis on July 21. Top Wealth Group Holding (TWG) – Hong Kong-based Top Wealth Group is engaged in environmental consulting, caviar production, and waste treatment services. On July 17, the company announced a 1-for-90 reverse stock split of its ordinary shares to regain compliance with Nasdaq's $1 minimum bid price rule and support its pending merger with Jilin Xiuzheng Agriculture & Animal Husbandry. TWG stock is expected to begin trading on a split-adjusted basis on July 21. CNS Pharmaceuticals (CNSP) – CNS Pharmaceuticals is a biotechnology company focused on developing anticancer drugs for primary and metastatic cancers of the brain and central nervous system. On July 15, the company announced a 1-for-12 reverse stock split of its common shares to comply with Nasdaq's minimum bid requirement. CNSP stock is expected to begin trading on a split-adjusted basis on July 22. Generation Bio (GBIO) – Focused on tackling rare and common genetic diseases, Generation Bio is developing next-gen non-viral gene therapies using its own closed-ended DNA platform. On July 18, the company announced a 1-for-10 reverse stock split to boost its share price and stay in compliance with Nasdaq listing rules. GBIO shares will begin trading on a split-adjusted basis starting July 22. Premium Catering Holdings (PC) – Serving up large-scale halal meals across Asia, Premium Catering Holdings is a key player in feeding construction crews and corporate events alike. On July 17, the Hong Kong-based company announced a 1-for-9 reverse stock split of its ordinary shares, a move aimed at boosting its share price and staying in line with Nasdaq's listing standards. PC stock is set to start trading on a split-adjusted basis on July 22.

Development black hole remains on West 57th Street
Development black hole remains on West 57th Street

New York Post

time4 hours ago

  • New York Post

Development black hole remains on West 57th Street

If West 57th Street between Sixth and Seventh avenues exemplifies Manhattan's regenerative energy, the block east between Fifth and Sixth avenues remains a black hole of development ambition. The 900-foot-long block — longer than three and a half midtown north-south blocks — looks gloomier every year as landowners hold out for magic-bullet combos of tenant commitments and construction financing. West of Bergdorf Goodman and the Crown Building stretches a procession of vacant lots, empty storefronts and scaffolding. At least four enormous sites await activity. Developers including Vornado, Lefrak, Soloviev, and at least one unknown outfit have kept their sites barren for years. There is a string of vacant lots, empty storefronts and scaffolding on West 57th Street west of Bergdorf Goodman and the Crown Building. New York Post At least four enormous sites await activity. New York Post The latest blows to the block were the closings of Brasserie 8 and a Half at Soloviev's 9 West and Rue 57 at the western corner. The opening soon of a small Abel Richard handbags boutique at 7 West is more than offset by large retail vacancies on either side of Nobu at 40 W. 57th and at the former locations of Mangia and other shops and cafes. Manhattan-based developer Sedesco, meanwhile, is demolishing a building to enlarge a site it's been assembling for more than 10 years between 37-47 W. 57th St. The supertall, mixed-use project is to be designed by 'starchitect' Rem Koolhaas' OMA studio. It will likely re-energize its surroundings. But no construction plans have yet been filed with the Department of Buildings.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store